Showing results (911-920 of 1,242) with videos related to
Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 4, 2025
Examining cognitive decline over time in Iranian ALS patients: Adapting successive versions B and C of the Edinburgh cognitive and behavioral screen to PersianZoha Shaka, Helia Mojtabavi, Morvarid Taebi, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 1, 2025
Incidence of ALS in all 50 states in the United States, data from the National ALS Registry, 2012-2019Paul Mehta, Jaime Raymond, Theresa Nair, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 20, 2024
Incidence of amyotrophic lateral sclerosis in ChilePatricia Lillo, Pedro Zitko, Gladys Godoy-Reyes, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 1, 2024
Incidence of amyotrophic lateral sclerosis before and during the COVID-19 pandemic: evidence from an 8-year population-based study in Central Italy based on healthcare utilization databasesFederico Maria Sopranzi, Andrea Faragalli, Marco Pompili, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 1, 2024
Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control studyStephen A Goutman, Jonathan Boss, Dae Gyu Jang, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 6, 2024
ALSUntangled #74: Withania Somnifera (Ashwagandha)Sartaj Jhooty, Paul Barkhaus, Andrew Brown, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 25, 2024
Peripheral immunity relate to disease progression and prognosis in amyotrophic lateral sclerosisQirui Jiang, Qianqian Wei, Lingyu Zhang, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2024
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional declineTatsuto Hamatani, Naoki Atsuta, Fumiya Sano, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 1, 2024
Investigating the impact of socioeconomic status on amyotrophic lateral sclerosisAli Shojaie, Ahmad Al Khleifat, Sarah Garrahy, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2024
Low CD3 level is a risk factor for amyotrophic lateral sclerosis: a Mendelian randomization studyWenzhi Yang, Xiangyi Liu, Dongsheng FanPageof 125